Drug Shortage Report for ADDERALL XR

Last updated on 2022-05-05 History
Report ID 159220
Drug Identification Number 02248812
Brand name ADDERALL XR
Common or Proper name Mixed salts amphetamine
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) MIXED SALTS AMPHETAMINE
Strength(s) 25MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size Bottles of 100's
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-04-21
Actual start date
Estimated end date 2022-06-24
Actual end date 2022-05-04
Shortage status Resolved
Updated date 2022-05-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-05-05 English Compare
v6 2022-05-04 French Compare
v5 2022-05-04 French Compare
v4 2022-05-04 English Compare
v3 2022-04-22 English Compare
v2 2022-04-21 French Compare
v1 2022-04-21 English Compare

Showing 1 to 7 of 7